Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive antimicrobial therapy for periodontitis
ISRCTN64254080Phase 4Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of amoxicillin and metronidazole in periodontitis, chronic periodontitis and Aggressive Periodontitis (AP) (2 arms), sponsored by Universitätsklinikum Münster. Primary endpoint: Percentage of sites showing attachment loss greater than or equal to 1.3 mm over 27.5 months. Started Jul 2008; status: completed.
02
Drugs
amoxicillinmetronidazole
03
Conditions
periodontitischronic periodontitisAggressive Periodontitis (AP)
Beyond the preview
Go deeper on ISRCTN64254080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN64254080.